BioDirection exhibiting at this year's 2019 MEDICA Conference in Düsseldorf, Germany

September 16, 2019

BioDirection is excited to be exhibiting at this year's 2019 MEDICA Conference in Düsseldorf, Germany!

Please visit us on November 18th - 21st in Hall 3, Booth C36-4 to learn more about BioDirection's Tbit™ System that uses a hand-held analyzer and single-use cartridge to deliver real-time, point-of-care diagnosis of traumatic brain injury in 90 seconds from a single drop of blood. The BioDirection Tbit™ System is currently for investigational use only. Visit us online at

About BioDirection, Inc.

BioDirection is a privately held medical device company developing cutting-edge and rapid point-of-care products for the objective diagnosis and management of concussion and other traumatic brain injury (TBI). The company's lead product, the Tbit System, delivers biologically-based results shown to accurately confirm a concussion in less than 90 seconds. BioDirection's platform utilizes a patented nanosensor technology with the potential for use in a wide range of applications in point-of-care diagnostics. To learn more about BioDirection, visit

Anthony Tremaglio
Vice President of Global Marketing
Tel: +1 617.440.4488

Sharad Joshi, President & CEO
BioDirection, Inc.
Tel: +1 508.599.2400

BioDirection is always searching for new opportunities. Contact us today with any questions or inquiries.